Sharps Technology, Inc. reported its third-quarter 2025 financial results, revealing a transformative shift to a Solana-based treasury strategy. The company raised $411 million through a private investment in public equity (PIPE) deal, comprising $267 million in cash and stablecoins and $144 million in SOL, bolstering its digital asset reserves.
As of October 31, 2025, Sharps holds over 2 million SOL, generating $17.7 million in staking revenue and fair-value gains. Executive Chairman Paul K. Danner emphasized that this move created the strongest balance sheet in the company's history, enabling a focus on medical device distribution and digital asset management after exiting syringe manufacturing.
Despite these efforts, Sharps' stock price plummeted to $2.86, down 7.14%, hitting record lows. The core business struggled, with only $83,622 in revenue against $1.2 million in manufacturing costs and $110.7 million in administrative expenses, leading to a net loss of $103 million for the quarter.
Solana's price decline exacerbated pressures, with SOL trading at $137.80, down nearly 30% in Q4 2025, reducing the value of Sharps' SOL holdings from $404 million to $275 million. Institutional confidence persisted, with over 20 digital asset trusts and two ETFs accumulating 24 million SOL, but market skepticism over the treasury strategy's viability remains high.
BTC
ETH
USDC
DOGE
MOCA
ZEC
XRP
ADA